Want to see SE:DVYSR full AI Analyst Report?
Devyser Diagnostics AB (DVYSR) Financial Statements
Devyser Diagnostics AB Financial Overview
Devyser Diagnostics AB's market cap is currently $928.94M. The company's EPS TTM is $0.92; its P/E ratio is 59.78; Devyser Diagnostics AB is estimated to report earnings on November 3, 2026, and the estimated EPS forecast is $0.07. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 250.50M | $ 216.90M | $ 169.30M | $ 126.61M | $ 93.48M |
| Gross Profit | $ 201.90M | $ 172.70M | $ 148.10M | $ 105.77M | $ 74.66M |
| Operating Income | $ 10.60M | $ -58.30M | $ -56.50M | $ -54.95M | $ -21.81M |
| EBITDA | $ 37.70M | $ -26.40M | $ -43.80M | $ -46.02M | $ -18.05M |
| Net Income | $ -8.40M | $ -61.50M | $ -53.60M | $ -45.95M | $ -20.73M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 77.50M | $ 144.50M | $ 262.90M | $ 363.60M | $ 377.64M |
| Total Assets | $ 469.70M | $ 473.80M | $ 510.10M | $ 500.63M | $ 456.87M |
| Total Debt | $ 51.90M | $ 59.10M | $ 74.80M | $ 21.20M | $ 12.96M |
| Net Debt | $ -25.60M | $ -85.40M | $ -188.10M | $ -342.40M | $ -364.68M |
| Total Liabilities | $ 115.40M | $ 124.80M | $ 125.00M | $ 69.19M | $ 40.18M |
| Stockholders' Equity | $ 354.30M | $ 349.10M | $ 385.10M | $ 431.44M | $ 416.68M |
| Cash Flow | |||||
| Free Cash Flow | $ 6.70M | $ -123.70M | $ -101.70M | $ -66.30M | $ -25.28M |
| Operating Cash Flow | $ 8.20M | $ -46.80M | $ -69.70M | $ -40.50M | $ -16.48M |
| Investing Cash Flow | $ -70.70M | $ -76.90M | $ -32.00M | $ -23.86M | $ -10.32M |
| Financing Cash Flow | $ -2.80M | $ 7.80M | $ -200.00K | $ 48.94M | $ 395.93M |
Currency in SEK
